Ridgetech Inc. has completed its transformation from a primarily retail pharmacy operator to a China-focused pharmaceutical wholesale distributor after its February 2025 restructuring and acquisition of Allright, an online and offline wholesale player. While offline bulk distribution remains the largest revenue source, rapid expansion through online platforms is reshaping the sales mix though pricing pressures have compressed gross margins. The company faces a competitive market dominated by local buyers with limited pricing power and ongoing operational integration costs. Regulatory constraints on capital flows and continuing internal control weaknesses pose material risks. Monitoring the evolution of sales mix, marketing efficiency, and regulatory compliance will be critical to assessing sustainability of growth and profitability.